NCT07018037View on ClinicalTrials.gov

Role of TTV During First-line Immunotherapy Treatment in Patients With Renal Cell Carcinoma

RecruitingOBSERVATIONAL

Enrollment

20

Participants

Timeline

Start Date

January 29, 2025

Primary Completion Date

January 29, 2026

Study Completion Date

January 29, 2027

Conditions

Renal Cell Carcinoma

Trial Locations (1)

00144

RECRUITING

"Regina Elena National Cancer Institute", Rome

All Listed Sponsors

lead

Regina Elena Cancer Institute

OTHER